title: Relationship of validated psychometric tools to subsequent medical utilization for asthma.
abstract: BACKGROUND
  Risk stratification is used to identify patients with asthma at increased risk of experiencing morbidity and resource utilization. Validated psychometric tools are infrequently studied sources of data for this purpose.
  
  
  OBJECTIVE
  To evaluate 4 types of validated psychometric tools as predictors for subsequent asthma utilization and determine their clinical usefulness.
  
  
  METHODS
  Eleven hundred patients with active asthma from a Health Maintenance Organization completed surveys that included demographic information and validated psychometric tools measuring generic quality of life (physical and mental components), asthma-specific quality of life, asthma control, and asthma symptom severity. Survey records were linked to administrative data that captured emergency department and hospital care, short-acting beta-agonist, and oral corticosteroid utilization for the year of and the year following the survey. Relationships of survey variables with subsequent utilization were assessed, adjusting for both baseline demographic and asthma utilization factors.
  
  
  RESULTS
  Scores of each psychometric tool were significantly related to subsequent utilization in univariate analyses and after adjusting for baseline utilization and demographic risk factors. Patients with higher scale-defined morbidity were as much as 4 times more likely to have subsequent utilization (sensitivity as high as 58%; specificity as high as 78%). Addition of an asthma-specific tool to either demographic or utilization prediction models added sensitivity (as much as 15%) but did not substantially improve the prediction properties of models containing both demographic and utilization predictors.
  
  
  CONCLUSIONS
  Validated psychometric tools appear useful for asthma risk stratification in individuals and in populations in which both utilization and demographic predictors are not available.
authors.affiliation: Department of Allergy, Kaiser-Permanente Medical Center, San Diego, Calif 92111, USA. michael.x.schatz@kp.org
authors.forename: Michael
authors.initials: M
authors.lastname: Schatz
authors.forename: David
authors.initials: D
authors.lastname: Mosen
authors.forename: Andrea J
authors.initials: AJ
authors.lastname: Apter
authors.forename: Robert S
authors.initials: RS
authors.lastname: Zeiger
authors.forename: William M
authors.initials: WM
authors.lastname: Vollmer
authors.forename: Thomas B
authors.initials: TB
authors.lastname: Stibolt
authors.forename: Albin
authors.initials: A
authors.lastname: Leong
authors.forename: Michael S
authors.initials: MS
authors.lastname: Johnson
authors.forename: Guillermo
authors.initials: G
authors.lastname: Mendoza
authors.forename: E Francis
authors.initials: EF
authors.lastname: Cook
mesh_terms: D000293:Adolescent; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data; D005260:Female; D006304:Health Status; D006306:Health Surveys; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D011594:Psychometrics / Q000379:methods; D011788:Quality of Life; D012307:Risk Factors
chemical_list: D018927:Anti-Asthmatic Agents